nephrology – Discover Pharma

Welcome to Discover Pharma! Today is : October 21, 2026

nephrology

Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics
Xeltis reports positive EU key trial results for aXess, showing superior patency and safety in hemodialysis
Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas
Hansa Biopharma reports statistically significant improvement in kidney function, supporting planned BLA submission
Hansa Biopharma AB has announced positive topline results from the [...]

May 5, 2026
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas
Xeltis poised for commercialization following positive EU pivotal trial results
Xeltis has announced successful clinical data from its aXess EU [...]

May 5, 2026
Uncategorised
FDA clears Daxor’s next-generation blood volume analyzer for precise fluid management
Daxor Corporation, a global leader in blood volume measurement technology, [...]

August 8, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK